Cargando…
The Nitric Oxide (NO) Donor Molsidomine Counteract Social Withdrawal and Cognition Deficits Induced by Blockade of the NMDA Receptor in the Rat
The deficiency of the gaseous molecule nitric oxide (NO) seems to be critically involved in the pathogenesis of schizophrenia. Thus, molecules that can normalize NO levels, as are NO donors, might be of utility for the medication of this psychiatric disease. The aim of the present study was to detec...
Autores principales: | Katsanou, Lamprini, Fragkiadaki, Evangelia, Kampouris, Sotirios, Konstanta, Anastasia, Vontzou, Aikaterini, Pitsikas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10095209/ https://www.ncbi.nlm.nih.gov/pubmed/37047839 http://dx.doi.org/10.3390/ijms24076866 |
Ejemplares similares
-
The Nitric Oxide (NO) Donor Molsidomine Attenuates Memory Impairments Induced by the D1/D2 Dopaminergic Receptor Agonist Apomorphine in the Rat
por: Vartzoka, Foteini, et al.
Publicado: (2023) -
Nitric Oxide Donor Molsidomine Positively Modulates Myogenic Differentiation of Embryonic Endothelial Progenitors
por: Tirone, Mario, et al.
Publicado: (2016) -
Therapeutic insight into molsidomine, a nitric oxide donor in streptozotocin-induced diabetic nephropathy in rats
por: Minaz, Nathani, et al.
Publicado: (2016) -
Examination of Imprinting Process with Molsidomine as a Template
por: Luliński, Piotr, et al.
Publicado: (2009) -
The Nitric Oxide (NO) Donor Sodium Nitroprusside (SNP) and Its Potential for the Schizophrenia Therapy: Lights and Shadows
por: Zoupa, Elli, et al.
Publicado: (2021)